Latest Treatment for depression Stories
SAN DIEGO, Oct. 30 /PRNewswire/ -- An expected 2,500 mental health professionals will convene at the San Diego Convention Center today for the 2008 U.S. Psychiatric and Mental Health Congress amid a deepening economic crisis causing new waves of anxiety disorders to ripple through American society.
By Cole, David Depression is more common among women than men, and researchers - including here - are studying the differences between the sexes, such as hormonal fluctuations and biochemical factors, for possible answers to why that's the case. Janice M.
SAINT LAURENT, QUEBEC and GREAT FALLS, VIRGINIA--(Marketwire - Oct. 9, 2008) - IntelGenx Corp. (TSX:IGX)(OTCBB:IGXT) ("IntelGenx") and Cary Pharmaceuticals Inc. ("Cary Pharma") today announced positive results from a clinical trial on its antidepressant CPI 300.
MALVERN, Pa., Oct. 8 /PRNewswire/ -- Neuronetics, Inc., a privately-held medical device company and a leader in the field of neuromodulation, announced today that the U.S.
Getting help for depression and anxiety has significant long-term benefits, a University of Alberta researcher said. Study leader Ian Colman said most people are not getting the type of treatment they need.
US-based biopharmaceutical company Rexahn Pharmaceuticals has received the FDA approval to begin Phase II trials for Serdaxin, for the treatment of major depressive disorders.
Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a leader in innovative therapeutics for life-threatening and life-debilitating diseases, announced today that the Company has received FDA approval to begin Phase II trials for Serdaxin(TM), for the treatment of major depressive disorders (MDD).
By Samuels, Noah Gropp, Cornelius; Singer, Shepherd Roee; Oberbaum, Menachem The use of complementary and alternative medicine (CAM) is on the rise, especially among psychiatric patients.
Numerous studies have shown the benefits of omega-3 fatty acids for everything from decreasing joint pain to improving cardiovascular and ophthalmologic health. Depression is another condition garnering attention from researchers studying the benefits of omega-3s.
RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced plans to advance its lead candidate Tyrima(TM) into Phase II trials for the treatment of depression and anxiety.
- A woman chauffeur.
- A woman who operates an automobile.